Avivomed
Minneapolis
About Avivomed
Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs. It focuses on commercializing neuromodulation technology platforms designed to treat patients suffering from chronic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $32.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2021)
- Website: avivomed.com
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/avivomed-62942 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.